NewGenIVF Group Ltd. operates as an assisted reproductive services provider. It focuses on providing fertility treatments to fulfil the dreams of building families.
Newgenivf Group stock last closed at $1.71, down 0.58% from the previous day, and has decreased 99.79% in one year. It has underperformed other stocks in the Medical Care Facilities industry by 0.77 percentage points. Newgenivf Group stock is currently +12.5% from its 52-week low of $1.52, and -99.91% from its 52-week high of $1,839.00.
At the moment, there are 2.27M NIVF shares outstanding. The market value of NIVF is $3.89M. In the past 24 hours, 73,000 NIVF shares were traded.
How to Buy Newgenivf Group Stock
Wondering how to invest in Newgenivf Group stock? Here's how.
Figure out where to buy Newgenivf Group stock: You need to decide on a stock brokerage, but don't worry - we've sifted through dozens of online brokerages and apps to help you decide where to buy Newgenivf Group stock.
Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
Fund your brokerage account: Pick your payment method and add your details.
Analyze Newgenivf Group stock: The Newgenivf Group ticker symbol is NIVF. Is Newgenivf Group stock a good investment? Should you buy shares of NIVF? How do NIVF's underlying business fundamentals look? Do top analysts think Newgenivf Group is a good buy? Why has NIVF's stock price moved recently? (Hint: Our stock market research website can help you decide if NIVF is a good stock to buy).
Make your NIVF purchase: Decide if you will purchase NIVF shares at the current market price or use a limit order to purchase NIVF stock at a specific price.
Watch your NIVF investment: Create a watchlist to watch your new investment in Newgenivf Group stock.
Step 1: Figure out where to buy Newgenivf Group stock
You need an online brokerage account to access the NASDAQ market and buy NIVF shares.
A brokerage account is an investment account that enables you to buy and sell a number of financial instruments, including stocks, bonds, mutual funds, and ETFs.
Our favorite brokerage: eToro
Based on our analysis, eToro is the best brokerage. Here's why:
You can invest in stocks with zero commissions: Invest without paying trading commissions.
Buy fractional shares: Even if you can't afford a full share, you can still invest in the stock.
Access to world markets: From Tech to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's top stock exchanges.
Social investing: eToro offers a community of more than 20 million users worldwide. Talk to, learn from, and copy the crypto trades of other investors.
Security: eToro is a regulated and licensed brokerage platform.
Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your stock purchase by opening an account with eToro now. This offer is only for US users.
eToro securities trading is offered by eToro USA Securities, Inc. (“the BD”), member of FINRA and SIPC. Cryptocurrency is offered by eToro USA LLC (“the MSB”) (NMLS: 1769299) and is not FDIC or SIPC insured. Investing involves risk, and content is provided for educational purposes only, does not imply a recommendation, and is not a guarantee of future performance. https://www.wallstreetzen.com is not an affiliate and may be compensated if you access certain products or services offered by the MSB and/or the BD.
Step 2: Sign up for a brokerage account
Now that you've picked the best brokerage, you'll need to fill out some personal details so you are able to buy NIVF stock today.
eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
Step 4: Analyze Newgenivf Group stock
After you have decided on the best place to buy Newgenivf Group stock, it's important to analyze their stock prior to investing, so you actually understand the risk as well as the upside.
Newgenivf Group shares quick numbers
NIVF Price
$1.71
1w %
-12.76%
1y %
-99.79%
5y %
N/A
P/E
0.01x
P/B
0.15x
P/S
0.02x
PEG
N/A
Revenue
$4.73M
Earnings
$9.88M
Fore. Rev. Growth
509.37%
Fore. Earn. Growth
-78.65%
Market Cap
$3.89M
Next Earnings
N/A
Next Dividend
N/A
Newgenivf Group Overview
WallStreetZen was designed to help part-time investors perform better fundamental analysis quickly.
Last year, NIVF earnings were $9.88M. Over the past 3 year, NIVF's earnings have grown by -99.95% per year. This was slower than the Medical Care Facilities industry average of 13.91%.
Last year, NIVF revenue was $4.73M. Over the last four year, NIVF's revenue has increased by 3.5% per year. This was slower than the Medical Care Facilities industry average of 9.36%.
No, Newgenivf Group doesn't provide an income stream by paying out dividends.
Get analysis from other traders
One of the primary reasons eToro is our favorite brokerage is because of its social trading community.
Click below to see what other community members have to say.
Step 5: Make your NIVF purchase
There are two primary order types:
Market order: A market order is an order to buy or sell a stock at the best available price. Market orders are generally fine.
Limit order: A limit order enables you to buy or sell a security at a specific price (or better). If you want to ensure you're buying or selling at a particular price, place a limit order.
Hit the Open button and your broker will place your order.
If you want additional assistance buying stocks on eToro, click the helpful video below:
How much does it cost to buy one Newgenivf Group share?
As of May 1, 2026, it costs $1.71 to buy one share of Newgenivf Group stock.
Remember, eToro's fractional share buying allows you to buy partial shares of stocks and ETFs. Even if you only have $0.86, you can buy 0.5 shares of NIVF.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.